Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363–385.
Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 2022;72:409–436.
Beckjord EB, Reynolds KA, van Londen GJ, et al. Population-level trends in posttreatment cancer survivors’ concerns and associated receipt of care: results from the 2006 and 2010 LIVESTRONG surveys. J Psychosoc Oncol 2014;32:125–151.
Burg MA, Adorno G, Lopez ED, et al. Current unmet needs of cancer survivors: analysis of open-ended responses to the American Cancer Society Study of Cancer Survivors II. Cancer 2015;121:623–630.
Weaver KE, Forsythe LP, Reeve BB, et al. Mental and physical health- related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012;21:2108–2117.
Emery J, Butow P, Lai-Kwon J, et al. Management of common clinical problems experienced by survivors of cancer. Lancet 2022;399:1537–1550.
Xu S, Thompson W, Ancoli-Israel S, et al. Cognition, quality-of-life, and symptom clusters in breast cancer: using Bayesian networks to elucidate complex relationships. Psychooncology 2018;27:802–809.
St Fleur RG, St George SM, Ream M, et al. A latent profile analysis to assess physical, cognitive and emotional symptom clusters in women with breast cancer. Psychol Health 2022;37:1253–1269.
de Ligt KM, de Rooij BH, Walraven I, et al. Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort. Support Care Cancer 2022;30:7873–7883.
Behringer K, Goergen H, Müller H, et al. Cancer-related fatigue in patients with and survivors of Hodgkin lymphoma: the impact on treatment outcome and social reintegration. J Clin Oncol 2016;34:4329–4337.
Von Ah D, Storey S, Tallman E, et al. Cancer, cognitive impairment, and work-related outcomes: an integrative review. Oncol Nurs Forum 2016;43:602–616.
Alanazi MT, Alanazi NT, Alfadeel MA, et al. Sleep deprivation and quality of life among uterine cancer survivors: systematic review. Support Care Cancer 2022;30:2891–2900.
Berger AM, Mitchell SA. Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Canc Netw 2008;6:3–13.
Slade AN, Waters MR, Serrano NA. Long-term sleep disturbance and prescription sleep aid use among cancer survivors in the United States. Support Care Cancer 2020;28:551–560.
Palesh O, Aldridge-Gerry A, Ulusakarya A, et al. Sleep disruption in breast cancer patients and survivors. J Natl Compr Canc Netw 2013;11:1523–1530.
Loh KP, Zittel J, Kadambi S, et al. Elucidating the associations between sleep disturbance and depression, fatigue, and pain in older adults with cancer. J Geriatr Oncol 2018;9:464–468.
Berrett-Abebe J, Cadet T, Pirl W, et al. Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol 2015;33:297–309.
Ahmedani BK, Peterson EL, Hu Y, et al. Major physical health conditions and risk of suicide. Am J Prev Med 2017;53:308–315.
Dirksen SR, Epstein DR. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 2008;61:664–675.
Palesh O, Aldridge-Gerry A, Zeitzer JM, et al. Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep 2014;37:837–842.
Lee S, Ma C, Shi Q, et al. Sleep and cancer recurrence and survival in patients with resected stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance). Br J Cancer. Published online May 13, 2023. doi:10.1038/s41416-023-02290-2
Zhou ES, Partridge AH, Syrjala KL, et al. Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv 2017;11:74–79.
Johnson JA, Rash JA, Campbell TS, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 2016;27:20–28.
Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021;17:255–262.
Kline CE, Sui X, Hall MH, et al. Dose-response effects of exercise training on the subjective sleep quality of postmenopausal women: exploratory analyses of a randomised controlled trial. BMJ Open 2012;2:e001044.
Rubio-Arias JÁ, Marín-Cascales E, Ramos-Campo DJ, et al. Effect of exercise on sleep quality and insomnia in middle-aged women: a systematic review and meta-analysis of randomized controlled trials. Maturitas 2017;100:49–56.
Yang PY, Ho KH, Chen HC, et al. Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review. J Physiother 2012;58:157–163.
Li L, Wang L, Sun Q, et al. Effect of two interventions on sleep quality for adolescent and young adult cancer survivors: a pilot randomized controlled trial. Cancer Nurs 2022;45:E560–572.
Cheville AL, Kollasch J, Vandenberg J, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage 2013;45:811–821.
Mishra SI, Scherer RW, Geigle PM, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev 2012;2012:CD007566.
Mustian KM, Sprod LK, Janelsins M, et al. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol 2013;31:3233–3241.
Rogers LQ, Fogleman A, Trammell R, et al. Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther 2013;12:323–335.
Van Gerpen RE, Becker BJ. Development of an evidence-based exercise and education cancer recovery program. Clin J Oncol Nurs 2013;17:539–543.
Mustian KM. Yoga as treatment of insomnia among cancer patients and survivors: a systematic review. Eur Med J Oncol 2013;1:106–115.
Rogers LQ, Courneya KS, Oster RA, et al. Physical activity and sleep quality in breast cancer survivors: a randomized trial. Med Sci Sports Exerc 2017;49:2009–2015.
Kim SW, Shin IS, Kim JM, et al. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci 2008;62:75–83.
Chen WY, Giobbie-Hurder A, Gantman K, et al. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat 2014;145:381–388.
Blume C, Garbazza C, Spitschan M. Effects of light on human circadian rhythms, sleep and mood. Somnologie (Berl) 2019;23:147–156.
Brown TM, Brainard GC, Cajochen C, et al. Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults. PLoS Biol 2022;20:e3001571.
Fleming L, Randell K, Harvey CJ, et al. Does cognitive behaviour therapy for insomnia reduce clinical levels of fatigue, anxiety and depression in cancer patients? Psychooncology 2014;23:679–684.
Heckler CE, Garland SN, Peoples AR, et al. Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial. Support Care Cancer 2016;24:2059–2066.
Rios P, Cardoso R, Morra D, et al. Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews. Syst Rev 2019;8:281.
Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017;13:307–349.
Thong MS, van Noorden CJ, Steindorf K, et al. Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol 2020;21:17.
Sleight AG, Crowder SL, Skarbinski J, et al. A new approach to understanding cancer-related fatigue: leveraging the 3P model to facilitate risk prediction and clinical care. Cancers (Basel) 2022;14:1982.
Schroder J, Mackenzie L. Outcomes related to activity performance and participation of non-pharmacological cancer-related fatigue interventions. OTJR (Thorofare, NJ) 2022;42:50–64.
Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999;85:1186–1196.
Piper BF, Dodd MJ, Ream E, et al. Better Health Through Nursing Research: International State of the Science. American Nurses Association; 1999.
Vannorsdall TD, Straub E, Saba C, et al. Interventions for multidimensional aspects of breast cancer-related fatigue: a meta-analytic review. Support Care Cancer 2021;29:1753–1764.
Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017;3:961–968.
Yuan Y, Lin L, Xie C, et al. Effectiveness comparisons of various psychosocial therapies for cancer-related fatigue: a Bayesian network meta-analysis. J Affect Disord 2022;309:471–481.
Hilfiker R, Meichtry A, Eicher M, et al. Exercise and other non- pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med 2018;52:651–658.
- Search Google Scholar
- Export Citation
, Hilfiker R , Meichtry A , Eicher M Exercise and other non- pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med 2018; 52: 651– 658. 28501804
Barsevick AM, Dudley W, Beck S, et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 2004;100:1302–1310.
de Raaf PJ, de Klerk C, Timman R, et al. Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial. J Clin Oncol 2013;31:716–723.
Hanna A, Sledge G, Mayer ML, et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 2006;14:210–215.
Gong S, Sheng P, Jin H, et al. Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS One 2014;9:e84391.
Qu D, Zhang Z, Yu X, et al. Psychotropic drugs for the management of cancer-related fatigue: a systematic review and meta-analysis. Eur J Cancer Care (Engl) 2016;25:970–979.
Mücke M, Mochamat M, Cuhls H, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2015;2015:CD006788.
Xiao P, Ding S, Duan Y, et al. Effect of light therapy on cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage 2022;63:e188–202.
Barton DL, Liu H, Dakhil SR, et al. Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 2013;105:1230–1238.
Sadeghian M, Rahmani S, Zendehdel M, et al. Ginseng and cancer- related fatigue: a systematic review of clinical trials. Nutr Cancer 2021; 73:1270–1281.
Arring NM, Millstine D, Marks LA, et al. Ginseng as a treatment of fatigue: a systematic review. J Altern Complement Med 2018;24:624–633.
Mandelblatt JS, Small BJ, Luta G, et al. Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living with cancer study. J Clin Oncol 2018;36:JCO1800140.
Janelsins MC, Heckler CE, Peppone LJ, et al. Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study. J Clin Oncol 2018;36:JCO2018786624.
Wagner LI, Gray RJ, Sparano JA, et al. Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results from TAILORx. J Clin Oncol 2020;38:1875–1886.
Schmidt JE, Beckjord E, Bovbjerg DH, et al. Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv 2016;10:302–311.
Janelsins MC, Heckler CE, Peppone LJ, et al. Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol 2017;35:506–514.
- Search Google Scholar
- Export Citation
, Janelsins MC , Heckler CE , Peppone LJ Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol 2017; 35: 506– 514. 28029304
Carroll JE, Nakamura ZM, Small BJ, et al. Elevated C-reactive protein and subsequent patient-reported cognitive problems in older breast cancer survivors: the Thinking and Living With Cancer study. J Clin Oncol 2023;41:295–306.
Schroyen G, Vissers J, Smeets A, et al. Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: a systematic review. Transl Oncol 2022;16:101297.
Li M, Caeyenberghs K. Longitudinal assessment of chemotherapy- induced changes in brain and cognitive functioning: a systematic review. Neurosci Biobehav Rev 2018;92:304–317.
Liou KT, Ahles TA, Garland SN, et al. The relationship between insomnia and cognitive impairment in breast cancer survivors. JNCI Cancer Spectr 2019;3:pkz041.
Schagen SB, Das E, Vermeulen I. Information about chemotherapy- associated cognitive problems contributes to cognitive problems in cancer patients. Psychooncology 2012;21:1132–1135.
Crouch A, Champion VL, Von Ah D. Comorbidity, cognitive dysfunction, physical functioning, and quality of life in older breast cancer survivors. Support Care Cancer 2022;30:359–366.
Fernandes HA, Richard NM, Edelstein K. Cognitive rehabilitation for cancer-related cognitive dysfunction: a systematic review. Support Care Cancer 2019;27:3253–3279.
Von Ah D, Crouch A. Cognitive rehabilitation for cognitive dysfunction after cancer and cancer treatment: implications for nursing practice. Semin Oncol Nurs 2020;36:150977.
Huang X, Zhao X, Li B, et al. Comparative efficacy of various exercise interventions on cognitive function in patients with mild cognitive impairment or dementia: a systematic review and network meta-analysis. J Sport Health Sci 2022;11:212–223.
Akbari PS, Hassan Y, Archibald L, et al. Effect of physical activity during chemotherapy on cognitive function in cancer survivors: a systematic review and meta-analysis. Physiother Can 2023;75:12–21.
Campbell KL, Zadravec K, Bland KA, et al. The effect of exercise on cancer-related cognitive impairment and applications for physical therapy: systematic review of randomized controlled trials. Phys Ther 2020;100:523–542.
Miladi N, Dossa R, Dogba MJ, et al. Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis. Support Care Cancer 2019;27:3717–3727.
Lawrence JA, Griffin L, Balcueva EP, et al. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. J Cancer Surviv 2016;10:176–184.
van der Linden SD, Gehring K, De Baene W, et al. Assessment of executive functioning in patients with meningioma and low-grade glioma: a comparison of self-report, proxy-report, and test performance. J Int Neuropsychol Soc 2020;26:187–196.
Boelsbjerg HB, Kurita GP, Sjøgren P, et al. Combining subjective and objective appraisals of cognitive dysfunction in patients with cancer: a deeper understanding of meaning and impact on suffering? Support Care Cancer 2022;30:3603–3612.
Ganz PA, Kwan L, Castellon SA, et al. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst 2013;105:791–801.